Zimmer Biomet releases third-quarter 2022 financial results
Click Here to Manage Email Alerts
Zimmer Biomet Holdings Inc. has announced its third-quarter 2022 financial results and updated its 2022 financial guidance, according to a company press release.
The company reported $1.670 billion in net sales, a decrease of 0.9% from the third quarter of 2021 and an increase of 5% on a constant currency basis. Zimmer Biomet also reported $194 million in net earnings for the quarter. According to the release, diluted earnings per share were $0.92 and adjusted diluted earnings per share were $1.58 in the quarter.
“We had another solid quarter, bolstered by our team’s execution and continued COVID-19 recovery. Our performance and successful navigation of current macro pressures further increase our confidence and enable us to raise our financial guidance,” Bryan Hanson, chair, president and CEO of Zimmer Biomet, said in the release. “We believe that our strategy is working, and our innovation pipeline and product portfolio position Zimmer Biomet to serve our customers and patients and deliver growth and value for our shareholders,” Hanson added.
Read more about
Click Here to Manage Email Alerts